Global deep brain stimulators market is expected to reach USD 1.59 billion by 2020, according to a new study by Grand View Research, Inc. Increasing incidence rates of target neurological disorders such as Parkinson’s and demand for minimally invasive surgical procedures are some primary factors expected to drive the deep brain stimulators market. Deep brain stimulators have witnessed a significant rise in usage rates and are now considered viable substitutes to conventional therapies.
Higher efficacy exhibited by the former is a key reason attributing to the aforementioned conclusion. Introduction of technological advancements such as fractionation of electric current and selective current steering are also expected to improve device usage rates. To request a sample copy or view summary of this report, click the link below: http://www.grandviewresearch.com/industry-analysis/deep-brain-stimulators-dbs-marketDeep brain stimulators are FDA approved when it comes to treating Parkinson’s, dystonia and OCD (obsessive compulsive disorder) etc. Moreover, the use of these devices for diseases such as trigeminal neuralgia, Tourette syndrome, Alzheimer’s, refractory epilepsy, cluster headache and movement disorders by multiple sclerosis are awaiting FDA approval.
The potential inclusion of new application areas is expected fuel the future growth of the market. To request or view other reports of this category, click the link below: http://www.grandviewresearch.com/industry/medical-devicesFurther key findings from the study suggest: • Parkinson’s disease was the largest application segment of the market in 2013. Use of deep brain stimulators for treating this disease renders symptomatic relief from medicine induced dyskinesia and therefore, these devices are expected to witness a rapid growth in demand during the forecast period. • OCD (obsessive compulsive disorder) was also one of the leading application segments in 2013.
DBS has proven to be the…
